Money Makes the World Go Round: the Pervasiveness of Pharmacoeconomics

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2008 Nov 27

PMID 19032720

Citations 1

Authors

J M Ritter

Affiliations

Soon will be listed here.

Citing Articles

From NCE to NICE: the role of pharmacoeconomics.

Hughes D Br J Clin Pharmacol. 2010; 70(3):317-9.

PMID: 20716229 PMC: 2949901. DOI: 10.1111/j.1365-2125.2010.03708.x.

References

Lambers Heerspink H, Knol M, Tijssen R, van Leeuwen T, Grobbee D, de Zeeuw D . Is the randomized controlled drug trial in Europe lagging behind the USA?. Br J Clin Pharmacol. 2008; 66(6):774-80. PMC: 2675759. DOI: 10.1111/j.1365-2125.2008.03296.x. View

Baber N, Smyth R . Introduction to tripartite meeting report (convenors: Dr Nigel Baber and Prof. Ros Smyth): towards establishing optimal doses for drugs prescribed to children. Br J Clin Pharmacol. 2005; 59(6):655-6. PMC: 1884873. DOI: 10.1111/j.1365-2125.2005.02426.x. View

Wide K, Larsson H, Bertilsson L, Diczfalusy U . Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. Br J Clin Pharmacol. 2008; 65(5):708-15. PMC: 2432481. DOI: 10.1111/j.1365-2125.2007.03078.x. View

Stephenson T . How children's responses to drugs differ from adults. Br J Clin Pharmacol. 2005; 59(6):670-3. PMC: 1884865. DOI: 10.1111/j.1365-2125.2005.02445.x. View

Muller A, Dorr P, Mouton J, de Jongh J, Oostvogel P, Steegers E . The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women. Br J Clin Pharmacol. 2008; 66(6):866-74. PMC: 2675777. DOI: 10.1111/j.1365-2125.2008.03292.x. View

Hennig S, Norris R, Kirkpatrick C . Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study. Br J Clin Pharmacol. 2007; 65(4):502-10. PMC: 2291370. DOI: 10.1111/j.1365-2125.2007.03045.x. View

Golder S, Loke Y . Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?. Br J Clin Pharmacol. 2008; 66(6):767-73. PMC: 2675760. DOI: 10.1111/j.1365-2125.2008.03272.x. View

Bero L, Oostvogel F, Bacchetti P, Lee K . Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007; 4(6):e184. PMC: 1885451. DOI: 10.1371/journal.pmed.0040184. View

Nath C, Earl J, Pati N, Stephen K, Shaw P . Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients. Br J Clin Pharmacol. 2008; 66(1):50-9. PMC: 2485261. DOI: 10.1111/j.1365-2125.2008.03166.x. View

10.

Mukattash T, Millership J, Collier P, McElnay J . Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol. 2008; 66(6):838-45. PMC: 2675756. DOI: 10.1111/j.1365-2125.2008.03290.x. View

11.

Yoon J, Jeong D, Oh J, Lee K, Lee H, Koh Y . The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection. Br J Clin Pharmacol. 2008; 66(6):854-60. PMC: 2675775. DOI: 10.1111/j.1365-2125.2008.03271.x. View

12.

Ritter J . Sensitivity: real (interferons, odorants) and imagined (homeopathy). Br J Clin Pharmacol. 2008; 65(2):151-3. PMC: 2291232. DOI: 10.1111/j.1365-2125.2007.03100.x. View

13.

Standing J, Howard R, Johnson A, Savage I, Wong I . Population pharmacokinetics of oral diclofenac for acute pain in children. Br J Clin Pharmacol. 2008; 66(6):846-53. PMC: 2675780. DOI: 10.1111/j.1365-2125.2008.03289.x. View

14.

Minhas R, Patel K . From rationing to rational: the evolving status of NICE. J R Soc Med. 2008; 101(9):436-42. PMC: 2587381. DOI: 10.1258/jrsm.2008.080167. View

15.

Betz U . How many genomics targets can a portfolio afford?. Drug Discov Today. 2005; 10(15):1057-63. DOI: 10.1016/S1359-6446(05)03498-7. View

16.

Camidge D, Oliver J, Skinner C, Attwood B, Nussey F, Jodrell D . The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes. Br J Clin Pharmacol. 2008; 65(2):224-9. PMC: 2291216. DOI: 10.1111/j.1365-2125.2007.02996.x. View

17.

Sismondo S . Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials. 2007; 29(2):109-13. DOI: 10.1016/j.cct.2007.08.001. View

18.

Albers S, Meibohm B, Mir T, Laer S . Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br J Clin Pharmacol. 2007; 65(4):511-22. PMC: 2291380. DOI: 10.1111/j.1365-2125.2007.03046.x. View

19.

Hawwa A, Collier P, Millership J, McCarthy A, Dempsey S, Cairns C . Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia. Br J Clin Pharmacol. 2008; 66(6):826-37. PMC: 2675766. DOI: 10.1111/j.1365-2125.2008.03281.x. View